Last Chance to See Chicago Enemy, Feb. 2 | Playbill

Related Articles
News Last Chance to See Chicago Enemy, Feb. 2 After two extensions, Chicago's Raven Theatre will close An Enemy of the People Sunday, Feb. 2. The show, which began previews Oct. 18 and opened Oct. 24, was first extended to Dec. 15, then Jan. 19, was recently extended through Feb. 2.

After two extensions, Chicago's Raven Theatre will close An Enemy of the People Sunday, Feb. 2. The show, which began previews Oct. 18 and opened Oct. 24, was first extended to Dec. 15, then Jan. 19, was recently extended through Feb. 2.

In 1950, American dramatist Arthur Miller adapted Henrik Ibsen's drama, about a community poisoned by its water well, to make it more up-to-date and accessible to modern audiences.

Raven Theatre's production is directed by the theatre's artistic director, Andrew Menendian, who chose the play because "it fits into many of Raven's missions. We've built a reputation on American classics, and we're trying to expand into classics from around the world. Enemy is the work of two great modern authors."

Menendian also pointed out Raven's happy association with playwright Miller. They've done four of his plays (All My Sons, A Memory Of Two Mondays, The Crucible, and Death Of A Salesman) in six years. Although Miller's never attended a Raven production, they do correspond with him. There's even a letter from Miller hanging in Raven Theatre's lobby, thanking them for their critically lauded production of A Memory Of Two Mondays.

Previous productions of An Enemy Of The People include a 1985 Off Broadway mounting at the Roundabout in New York (starring Roy Dotrice), and a 1990 production on PBS-TV starring John Glover. The next Raven show will be Athol Fugard's Road To Mecca, opening March 14.

For tickets or information on An Enemy Of The People, call (312) 338-2177.

-- By David Lefkowitz

 
RELATED:
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!